952 Phase II trial of AV-GBM-1: dendritic cell vaccine pulsed with lysate enriched for autologous tumor-initiating cell antigens in the treatment of patients with newly diagnosed glioblastoma

• Gabriel Nistor,
• Robert Dillman,
• Daniela Bota,
• David Piccioni,
• Christopher Duma,
• Renato LaRocca,
• Santosh Kesari,
• Jose Carrillo,
• Robert Aiken,
• Frank Hsu,
• Thomas Taylor,
• Mehrdad Abedi,
• Xiaotang Kong,
• Candace Hsieh

Affiliations

Gabriel Nistor

Aff7 Neostem OncologyLLC Irvine United States

Robert Dillman

Aff7 Neostem OncologyLLC Irvine United States

Daniela Bota

1Unviersity of California, Irvine, Orange, USA

David Piccioni

3UCSD, San Diego, CA, USA

Christopher Duma

4Hoag Hospital, Newport Beach, CA, USA

Renato LaRocca

5Norton Cancer Center, Louisville, KY, USA

Santosh Kesari

6John Wayne Cancer Institute, Santa Monica, California, USA

Jose Carrillo

6John Wayne Cancer Institute, Santa Monica, California, USA

Robert Aiken

8Rutgers, New Brunswick, NJ, USA

Frank Hsu

2UCI, Orange, USA

Thomas Taylor

Clinical Radiology, Ninewells Hospital and Medical School, Dundee, UK

Mehrdad Abedi

6UC Davis, Sacramento, CA, USA

Xiaotang Kong

1University of California Irvine, Orange, CA, USA

Candace Hsieh

8AIVITA Biomedical, Inc, Irvine, CA, USA